Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gavish

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Harefuah|October 30, 2001
[Atherosclerosis as an autoimmune disease]D Gavish, E Leibovitz
Lancet (London, England)|January 26, 1991
Lipoprotein(a) reduction by N-acetylcysteineD Gavish, J L Breslow
Journal of Lipid Research|March 1, 1987
In vivo conversion of human HDL3 to HDL2 and apoE-rich HDL1 in the rat: effects of lipid transfer proteinD Gavish, Y Oschry, S Eisenberg
Israel Journal of Medical Sciences|June 1, 1996
Diurnal heterogeneity in structure and function of low density lipoproteins of normolipidemic malesM Fainaru, D Gavish, Z Schafer
Journal of Clinical Gastroenterology|December 1, 1985
Early and late onset ulcerative colitis: distinct clinical featuresJ Zimmerman, D Gavish, D Rachmilewitz
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 12, 2015
Does metformin treatment influence bone formation in patients with nonalcoholic fatty liver disease?E Soifer, D Gavish, M Shargorodsky
The Journal of Clinical Investigation|December 1, 1989
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) geneD Gavish, N Azrolan, J L Breslow
The Journal of Biological Chemistry|July 25, 1991
Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey modelN Azrolan, D Gavish, J L Breslow
Harefuah|November 16, 1986
[Primary familial hyper-alpha-lipoproteinemia in Israel]D Raveh, A Israeli, D Gavish, et al.
Journal of Internal Medicine|May 16, 2000
Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safetyD Gavish, E Leibovitz, I Shapira, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Harefuah|October 30, 2001
[Atherosclerosis as an autoimmune disease]D Gavish, E Leibovitz
Lancet (London, England)|January 26, 1991
Lipoprotein(a) reduction by N-acetylcysteineD Gavish, J L Breslow
Journal of Lipid Research|March 1, 1987
In vivo conversion of human HDL3 to HDL2 and apoE-rich HDL1 in the rat: effects of lipid transfer proteinD Gavish, Y Oschry, S Eisenberg
Israel Journal of Medical Sciences|June 1, 1996
Diurnal heterogeneity in structure and function of low density lipoproteins of normolipidemic malesM Fainaru, D Gavish, Z Schafer
Journal of Clinical Gastroenterology|December 1, 1985
Early and late onset ulcerative colitis: distinct clinical featuresJ Zimmerman, D Gavish, D Rachmilewitz
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 12, 2015
Does metformin treatment influence bone formation in patients with nonalcoholic fatty liver disease?E Soifer, D Gavish, M Shargorodsky
The Journal of Clinical Investigation|December 1, 1989
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) geneD Gavish, N Azrolan, J L Breslow
The Journal of Biological Chemistry|July 25, 1991
Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey modelN Azrolan, D Gavish, J L Breslow
Harefuah|November 16, 1986
[Primary familial hyper-alpha-lipoproteinemia in Israel]D Raveh, A Israeli, D Gavish, et al.
Journal of Internal Medicine|May 16, 2000
Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safetyD Gavish, E Leibovitz, I Shapira, et al.
Pageof 5